ライフサイエンスコーパス: were randomly assigned

1 Of the 229 patients enrolled, 153 were randomly assigned to receive luspatercept and 76 to rece

2 Of these, 197 (34%) were randomly assigned to receive 150 mg S44819 twice a day,

3 ith immune thrombocytopenia were screened, of whom 74 (80%) were randomly assigned: 38 to eltrombopag and 36 to intraveno

4 computer-generated list, T. trichiura-infected adolescents were randomly assigned to 7 treatment arms: 8, 16, or 24 mg o

5 creased risk of developing breast cancer were recruited and were randomly assigned (1:1) to either anastrozole (1 mg per

6 persistent atrial fibrillation in sinus rhythm at baseline were randomly assigned in a 1:1 ratio to either abstain from

7 h HIV and not on ART with detectable viral load at baseline were randomly assigned; 666 (51%) were men.

8 15 communities were randomly assigned to receive HIV prevention and treatmen

9 tatic urothelial carcinoma, from 221 sites in 35 countries, were randomly assigned to receive atezolizumab plus platinum-

10 ocardial infarction and multivessel coronary artery disease were randomly assigned to one of the following revascularizat

11 Patients with MYD88L265P disease were randomly assigned 1:1 to treatment with ibrutinib or zan

12 who were recently hospitalized for worsening heart failure were randomly assigned to receive sotagliflozin or placebo.

13 ), with refractory agitation, despite low-dose haloperidol, were randomly assigned to receive intravenous haloperidol dos

14 65 years), who were HIV-uninfected and at low-risk for HIV, were randomly assigned (3:1) to long-acting injectable cabote

15 ), abdominally obese or dyslipidemic participants in Israel were randomly assigned to healthy dietary guidelines, Mediter

16 254 women, recruited at 29 hospitals in the United Kingdom, were randomly assigned: 127 to the myomectomy group (of whom

17 level of 400 mg per deciliter (4.5 mmol per liter) or less were randomly assigned in a 2:1 ratio to receive monthly subc

18 or IIIC (without in-transit metastasis) cutaneous melanoma were randomly assigned to receive pembrolizumab at a flat dos

19 Groups of 8 weeks old mice were randomly assigned to receive chow diet, high fat diet wi

20 igible (TIE) patients with newly diagnosed multiple myeloma were randomly assigned to D-Rd (n = 368) or Rd (n = 369).

21 Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or co

22 Participants were randomly assigned into 5 weight loss maintenance diets b

23 Participants were randomly assigned to a 52-minute intravenous administrat

24 Participants were randomly assigned to a 6-week intranasal oxytocin (48IU/

25 Participants were randomly assigned to either GumChucks or SF.

26 Participants were randomly assigned to either undergo prophylactic negativ

27 Participants were randomly assigned to once-daily oral fixed-dose combinat

28 Participants were randomly assigned to one of five groups and then further

29 20 099 participants were randomly assigned and vaccinated between Sept 7, 2016, a

30 week lead-in period of cognitive training, 100 participants were randomly assigned to receive either vortioxetine or plac

31 629 participants were randomly assigned and treated in study 1 (314 to bictegr

32 Enrolled participants were randomly assigned (1:1) to receive intramuscular fulvest

33 he time of percutaneous coronary intervention, participants were randomly assigned to prospective rapid point-of-care gen

34 In the historical control trial, participants were randomly assigned to either one dose or two doses of mon

35 IPV-vaccinated participants were randomly assigned to receive two doses of either novel O

36 Patients were randomly assigned (1:1:1) centrally via an interactive v

37 Patients were randomly assigned (1:1:1) in blocks of six, stratified b

38 Patients were randomly assigned 1:1 to empagliflozin 10 mg once daily

39 Patients were randomly assigned to catheter ablation alone (n = 158) o

40 Patients were randomly assigned to the short-term (8 to 10 weeks) or l

41 Between March 25, 2015 and April 23, 2018, 174 patients were randomly assigned, and 168 (83 on afatinib + cetuximab a

42 Between March 11, 2016, and June 22, 2018, 62 patients were randomly assigned to nivolumab (n = 30) or nivolumab plu

43 ed to be deriving benefit despite radiographic progression, were randomly assigned to continue nivolumab until disease pr

44 -wk run-in period on a nitrate-restricted diet the subjects were randomly assigned to receive 1 of the following 3 interv

45 , 1,493 participants with 6 or fewer cycles of attempt time were randomly assigned with 50% probability to receive 12 Cle

46 Villages were randomly assigned (1:1:1) to one of three groups: group-

47 The primary endpoint, analysed in all participants who were randomly assigned and attended at least one follow-up vi

48 emala included 26 mother-infant dyads 4-6 mo postpartum who were randomly assigned to receive 3 treatments in a random or

49 Overall, 44 clusters (69 330 pregnant women) were randomly assigned to intervention (22 clusters [36 008 p

50 Adolescents (n = 130; 15-19 years) were randomly assigned 1:1:1 to NET-EN, CCVR, or COCPs for 16